PRA Acquisition of Pharma Bio-Research May Lead to New Drug Development Labs in US

PRA International (Reston, VA, www.prainternational.com) has completed the acquisition of Pharma Bio-Research (Zuidlaren, The Netherlands), an early-phase clinical development and bioanalytical company. Plans for PRA International to acquire Pharma Bio-Research were originally announced on June 19. The acquisition, valued at 84.6 million Euros, provides PRA International with early-phase development and bioanalytical laboratory facilities in Europe. PRA also expects to draw on Pharma Bio-Research’s expertise to establish drug development laboratory facilities in the US for biotech and pharmaceutical clients.